Inspire Medical Systems, Inc. (NYSE:INSP) receives a "Buy" rating from Stifel Nicolaus with a price target of $110, indicating a potential increase of 22.4%.The company is currently facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934.Despite legal challenges, INSP's stock price shows an increase, with a current price of $89.87 and a trading volume of 1,073,158 shares on the NYSE.Inspire Medical Systems, Inc. (NYSE:INSP) is a company that specializes in innovative medi ...